Arthur Suckow, Ph.D. Executive Advisor

Dr. Suckow is the founder and CEO of DTx Pharma, an RNA therapeutics company recently acquired by Novartis. Prior to DTx, he various scientific roles at Johnson & Johnson and AstraZeneca and has over a decade of experience developing drugs utilizing fatty acids. Dr. Suckow has recent experience in raising angel, venture and grant funding and an understanding of how to build datasets, teams and infrastructure to achieve critical inflection points that resonate with investors and large pharma. Dr. Suckow received his Ph.D. in Biomedical Sciences from University of California, San Diego (UCSD) and completed postdoctoral work at UCSD and Johnson & Johnson.